Abbott Laboratories (NYSE:ABT) Abbott Laboratories (NYSE:ABT) is scheduled to release its Q2 2013 earnings results before the market open on Wednesday, July 17. Analysts expect the company to report revenue of $5.52 billion, and the average EPS estimate is for $0.44. Abbott reported $0.42 EPS for the first quarter, beating the consensus estimate of $0.41 by $0.01. Revenue for the period came in at $5.38 billion, compared to expectations for $5.42 billion. The company recently declared a quarterly dividend of $0.14 per share, payable on August 15, to stockholders of record July 15. The stock has a 1-year high of…
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
